Back to Search
Start Over
The prognostic value of plasma fibrinogen level in patients with acute myeloid leukemia: a systematic review and meta-analysis.
- Source :
- Leukemia & Lymphoma; Nov2020, Vol. 61 Issue 11, p2682-2691, 10p
- Publication Year :
- 2020
-
Abstract
- Increasing evidence has revealed that plasma fibrinogen levels may serve as prognostic indicators in patients with acute myeloid leukemia (AML), yet the exact association is still elusive. We conducted a systematic review and meta-analysis of all available studies concerning the relationship between plasma fibrinogen level and survival in AML patients. The pooled hazard ratio (HR) and 95% confidence intervals (CIs) for overall survival (OS) were calculated to evaluate the effect. A random-effect model was applied and the robustness of the pooled results was confirmed by subgroup and sensitivity analysis. A total of 9 studies were eligible to assess the association between plasma fibrinogen level and prognosis in AML. Among these investigations above, 5 studies adopted OS as their outcome indicator and were selected for the final meta-analysis. The pooled result suggested that plasma fibrinogen level was significantly relevant to increased mortality risk in AML patients (HR = 1.21, 95% CI: 1.01–1.44, p =.000, I<superscript>2</superscript>=85.4%). In conclusion, high plasma fibrinogen level may independently predict worse OS in patients with AML. [ABSTRACT FROM AUTHOR]
- Subjects :
- ACUTE myeloid leukemia
PROGNOSIS
Subjects
Details
- Language :
- English
- ISSN :
- 10428194
- Volume :
- 61
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Leukemia & Lymphoma
- Publication Type :
- Academic Journal
- Accession number :
- 146928514
- Full Text :
- https://doi.org/10.1080/10428194.2020.1780587